FY2026 Earnings Forecast for YMAB Issued By HC Wainwright
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Investment analysts at HC Wainwright issued their FY2026 earnings estimates for shares of Y-mAbs Therapeutics in a report released on Monday, May 19th. HC Wainwright analyst R. Burns anticipates that the company will earn ($0.92) per share for the year. HC Wainwright has a “Buy” rating and […]
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB – Free Report) – Investment analysts at HC Wainwright issued their FY2026 earnings estimates for shares of Y-mAbs Therapeutics in a report released on Monday, May 19th. HC Wainwright analyst R. Burns anticipates that the company will earn ($0.92) per share for the year. HC Wainwright has a “Buy” rating and […]
